Avanos Medical, Inc. To Present At The UBS Healthcare Conference 2024
Date
11/8/2024 4:31:04 PM
(MENAFN- PR Newswire)
ALPHARETTA, Ga., Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS ) today announced that
Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare conference on Tues., Nov. 12
at approximately
2:45 p.m. Pacific Time.
A webcast of the conference presentation will be available on the
Investors section
of the Avanos Medical website and will be archived on that site.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS ) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit Avanos and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.
SOURCE Avanos Medical
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN08112024003732001241ID1108866822
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.